赤痢菌検査キットの世界市場

赤痢菌検査キットの世界市場は2030年までに1億4,500万米ドルに達する見込み

2024年に1億1,010万米ドルと推定される赤痢菌検査キットの世界市場は、2030年には1億4,500万米ドルに達すると予測され、分析期間2024-2030年のCAGRは4.7%で成長すると予測されます。本レポートで分析したセグメントの1つであるラテラルフローアッセイ試験は、CAGR 6.1%を記録し、分析期間終了までに5,550万米ドルに達すると予測されます。酵素結合免疫吸着測定法（Enzyme-linked Immunosorbent Assay Test）分野の成長率は、分析期間中CAGR 3.6%と推定されます。

米国市場は3,000万米ドルと推定、中国はCAGR 7.7％で成長予測

米国の赤痢菌検査キット市場は、2024年に3,000万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 7.7%で推移し、2030年までに2,890万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.1％と4.8％と予測されています。欧州では、ドイツがCAGR 3.0%で成長すると予測されています。

世界の赤痢菌検査キット市場- 主要動向と促進要因のまとめ

赤痢菌診断薬および検査キット開発におけるイノベーションの原動力とは？

赤痢菌検査キット市場は、特に5歳未満の小児や衛生インフラが不十分な地域における赤痢菌症の負担に対する世界の意識の高まりにより、急速に発展しています。従来の培養に基づく方法は正確ではあるが、より迅速で特異的な検出が可能な分子や免疫測定に基づく診断キットに取って代わられつつあります。ラテラルフロー免疫測定法、リアルタイムPCR測定法、ELISAベースのキットは、アウトブレイクの迅速な検出と治療モニタリングのために、臨床検査機関や公衆衛生機関で採用されるようになってきています。これらのキットは複数の血清群や亜型を対象としており、多くの場合、赤痢菌と腸管侵入性大腸菌（EIEC）のような近縁の病原体を区別しています。

マルチプレックス診断の技術的進歩により、単一のアッセイで赤痢菌と他の消化管病原体を検出するシンドロミック・パネルの出現により、競合情勢は大きく変わりつつあります。特に難民キャンプ、緊急診療所、低資源環境におけるポイントオブケア診断の需要が、最小限のトレーニングで30分以内に結果が得られる携帯型バッテリー駆動検査キットの開発を後押ししています。企業は、現場での展開と高感度検出のために、マイクロ流体ベースのシステムとCRISPR対応診断薬に投資しています。さらに、凍結乾燥試薬や常温安定型キットの開発により、熱帯地域におけるコールドチェーン物流への依存度が低下しています。

世界の公衆衛生への取り組みと地域的な疾病サーベイランスプログラムは市場導入にどのような影響を与えているか？

WHO、CDC、Gaviなどの組織による世界の公衆衛生イニシアチブは、標準化され、拡張可能で、手頃な価格の赤痢菌検査キットの需要に強い影響を与えています。赤痢菌は、その抗菌薬耐性（AMR）の増加により、WHOの研究開発計画（R&D Blueprint）の優先病原体に分類されており、スチュワードシップと封じ込めのために迅速な診断が不可欠となっています。サハラ以南のアフリカ、南アジア、東南アジアでは、大規模なワクチン接種試験やサーベイランス・プログラムが実施されており、診断薬メーカー、特に世界保健ガイドラインに沿ったPCRやELISAベースのサーベイランス・プラットフォームを提供するメーカーにとって、大きなビジネスチャンスとなっています。

地域政府と非営利の保健連合は、特に学校、スラム、難民キャンプを対象とした疾病監視ネットワークを拡大しています。このような環境では、使いやすく、正確な結果が得られ、疫学的報告をサポートする検査キットが優先されます。診断薬開発企業は、データの標準化と国家疾病データベースへの統合を確実にするため、デジタル読み出しインターフェース、クラウドベースの報告、アプリ接続型リーダーを統合することで対応しています。WHOの事前認定やCE-IVDの承認を受けたキットは、ドナー資金によるプログラムでより容易に採用されています。さらに、統合された疾病サーベイランスと対応（IDSR）の枠組みに赤痢菌が含まれることは、アフリカと南アジア全域の公的調達量に影響を及ぼしています。

製品のアクセシビリティと使用に影響を与える規制上・技術上の課題とは？

赤痢菌検査キット市場は、特に国境を越えた使用、病原体株のばらつき、品質保証の観点から、複数の規制、技術、運用上の課題に直面しています。赤痢菌は複数の血清群（S. dysenteriae、S. sonnei、S. flexneri、S. boydii）から構成され、しばしば異なる地域で共存し、治療に対する反応も異なります。このような多様性から、他の腸内病原体との交差反応性を最小限に抑えつつ、幅広い菌株レパートリーを高い感度と特異性で検出するキットが必要とされています。検査開発者はまた、性能ベンチマークの整合性を高める必要性にも取り組んでいます。特に、多くの検査キットはインフラが限られた非公式または現場環境で使用されるためです。

多くの中低所得国では、関税規制、現地でのバリデーション研究の欠如、診断検査に対する償還制度の制限などが原因で、質の高い診断薬へのアクセスが妨げられています。場合によっては、国の必須診断薬リストにはまだ赤痢菌が単独の検査項目として含まれておらず、施設での採用が減少しています。さらに、ポイント・オブ・ケア検査の精度は、取り扱いプロトコール、環境条件、試薬の品質の順守に左右されることが多く、これらは展開環境によって大きく異なる可能性があります。このようなギャップに対処するため、メーカー各社はばらつきを抑えるためのコントロール、バッファシステム、エラー防止サンプル処理モジュールを組み込んだ統合キットの開発に取り組んでいます。

診断薬へのアクセスを改善するための取り組みとしては、地域の製造ハブ、技術移転プログラム、高負荷地域への検査キット調達の助成を目的とした官民パートナーシップなどがあります。また、地域の検査精度に対する信頼性を高めるため、第三者による熟練度試験プログラムや外部品質評価スキームも普及しつつあります。さらに、検査キット企業は、十分なサービスを受けていない地域における診断能力向上のため、自社製品にトレーニングモジュールやメンテナンスサービスをバンドルするケースが増えています。

赤痢菌検査キット市場の成長を促進する主な要因は何か？

世界の赤痢菌検査キット市場の成長は、腸疾患診断と迅速な感染症サーベイランスの優先順位が高まっていることを反映するいくつかの要因によって牽引されています。主な成長要因は、流行地域および旅行関連集団の両方における赤痢罹患率の上昇であり、これにより、迅速で信頼性が高く、分散型の診断ソリューションに対するニーズが高まっています。赤痢菌の抗菌薬耐性が高まる中、原因菌をタイムリーかつ正確に特定することは、効果的な治療を決定し、アウトブレイクを封じ込めるために不可欠です。そのため、病院、診療所、公衆衛生機関は、AMRサーベイランスの枠組みやWHOの治療ガイドラインに沿った診断キットに投資しています。

もう一つの大きな推進力は、開発途上国における診断インフラと資金の拡大です。大規模な保健調査、ドナー資金による衛生プログラム、栄養に焦点を当てた小児保健キャンペーンは、赤痢菌検査キットに対する安定した需要を生み出しています。日常的な予防接種、出生前スクリーニング、学校での衛生プログラムに診断検査が組み込まれることで、迅速かつ携帯可能な診断ツールの使用事例が拡大しています。多国籍援助機関や財団は、水系病原体と子どもたちの栄養不良との間に重要な関係があることを認識し、WASH（水、衛生、保健）プログラムのサプライチェーンに診断薬を組み入れる傾向を強めています。

この成長軌道は、等温増幅プラットフォーム、スマートフォン対応アッセイ、AIによる結果解釈など、ポータブル診断薬の技術的進歩にも支えられています。これらの技術革新により、正確な検査を行うためのスキルの閾値やインフラ要件が低減され、移動診療所、緊急対応チーム、地域医療従事者プログラムにおける新たなエンドユーザー層が開拓されつつあります。診断薬がより広範な公衆衛生介入に統合されるにつれて、業界別キーワード市場は、医療システム全体における垂直的・水平的な需要の両方から恩恵を受けることが期待されます。

セグメント

検査タイプ（ラテラルフローアッセイ検査、酵素結合免疫吸着アッセイ検査、ポリメラーゼ連鎖反応アッセイ検査、その他の検査タイプ）、技術（従来の診断検査技術、核酸ベースの検査技術、その他の技術）、エンドユーザー（病院エンドユーザー、診断研究所エンドユーザー、研究機関エンドユーザー、その他のエンドユーザー）

調査対象企業の例

• Abbott Laboratories
• Alere Inc.（Abbott）
• BioMerieux SA
• BioPerfectus（BioPerfectus Tech）
• Bio-Rad Laboratories, Inc.
• Cepheid（Danaher）
• Coris BioConcept
• Creative Diagnostics
• CTK Biotech, Inc.
• DiaSorin S.p.A.
• Fujirebio Diagnostics, Inc.
• Hardy Diagnostics
• Hygiena LLC
• Luminex Corporation
• Meridian Bioscience, Inc.
• Molbio Diagnostics Pvt. Ltd.
• MP Biomedicals LLC
• QIAGEN N.V.
• Sekisui Diagnostics LLC
• Thermo Fisher Scientific Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Shigella Test Kits Market to Reach US$145.0 Million by 2030

The global market for Shigella Test Kits estimated at US$110.1 Million in the year 2024, is expected to reach US$145.0 Million by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Lateral Flow Assays Test, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$55.5 Million by the end of the analysis period. Growth in the Enzyme-linked Immunosorbent Assay Test segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$30.0 Million While China is Forecast to Grow at 7.7% CAGR

The Shigella Test Kits market in the U.S. is estimated at US$30.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$28.9 Million by the year 2030 trailing a CAGR of 7.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.1% and 4.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.0% CAGR.

Global Shigella Test Kits Market - Key Trends & Drivers Summarized

What Is Driving Innovation in Shigella Diagnostics and Test Kit Development?

The Shigella test kits market is evolving rapidly due to rising global awareness about the burden of shigellosis, especially in children under five and in regions with inadequate sanitation infrastructure. Traditional culture-based methods, although accurate, are being replaced by molecular and immunoassay-based diagnostic kits that provide faster and more specific detection. Lateral flow immunoassays, real-time PCR assays, and ELISA-based kits are being increasingly adopted by clinical laboratories and public health institutions for rapid outbreak detection and treatment monitoring. These kits target multiple serogroups and subtypes, often distinguishing between Shigella and closely related pathogens like enteroinvasive E. coli (EIEC).

Technological advancement in multiplex diagnostics is reshaping the competitive landscape, with the emergence of syndromic panels that detect Shigella alongside other gastrointestinal pathogens in a single assay. The demand for point-of-care diagnostics, particularly in refugee camps, emergency clinics, and low-resource settings, is driving the development of portable and battery-powered test kits that require minimal training and yield results within 30 minutes. Companies are investing in microfluidic-based systems and CRISPR-enabled diagnostics for field-based deployment and high-sensitivity detection. Additionally, the development of lyophilized reagents and ambient-temperature-stable kits is reducing reliance on cold chain logistics in tropical regions.

How Are Global Health Initiatives and Regional Disease Surveillance Programs Influencing Market Adoption?

Global public health initiatives by organizations such as the WHO, CDC, and Gavi are exerting a strong influence on the demand for standardized, scalable, and affordable Shigella test kits. Shigella is classified as a priority pathogen under the WHO-s R&D Blueprint due to its growing antimicrobial resistance (AMR), which has made fast diagnosis critical for stewardship and containment. Mass vaccination trials and surveillance programs across sub-Saharan Africa, South Asia, and Southeast Asia are creating large-scale opportunities for diagnostic manufacturers, especially those offering PCR and ELISA-based surveillance platforms aligned with global health guidelines.

Regional governments and non-profit health alliances are scaling up disease surveillance networks, particularly targeting schools, slums, and refugee camps. In these settings, test kits that are easy to use, deliver accurate results, and support epidemiological reporting are prioritized. Diagnostic developers are responding by integrating digital readout interfaces, cloud-based reporting, and app-connected readers to ensure data standardization and integration into national disease databases. Kits with WHO prequalification or CE-IVD approval are more readily adopted in donor-funded programs. Moreover, the inclusion of Shigella in Integrated Disease Surveillance and Response (IDSR) frameworks is influencing public procurement volumes across Africa and South Asia.

What Regulatory and Technical Challenges Impact Product Accessibility and Use?

The Shigella test kit market is challenged by multiple regulatory, technical, and operational hurdles, particularly in the context of cross-border use, pathogen strain variability, and quality assurance. Shigella comprises multiple serogroups-S. dysenteriae, S. sonnei, S. flexneri, and S. boydii-which often co-circulate in different geographies and respond differently to treatments. This diversity necessitates kits that detect broad strain repertoires with high sensitivity and specificity, while minimizing cross-reactivity with other enteric pathogens. Test developers are also grappling with the need for greater harmonization of performance benchmarks, especially as many test kits are deployed in informal or field settings with limited infrastructure.

Access to quality diagnostics is hindered in many low- and middle-income countries due to customs regulations, lack of local validation studies, and limited reimbursement mechanisms for diagnostic testing. In some cases, national essential diagnostics lists have yet to include Shigella as a standalone test item, reducing institutional adoption. Additionally, the accuracy of point-of-care tests is often dependent on adherence to handling protocols, ambient conditions, and reagent quality-factors that can vary significantly across deployment environments. To address these gaps, manufacturers are working on integrated kits with built-in controls, buffer systems, and error-proof sample processing modules to reduce variability.

Efforts to improve diagnostic access include regional manufacturing hubs, technology transfer programs, and public-private partnerships aimed at subsidizing test kit procurement for high-burden areas. Third-party proficiency testing programs and external quality assessment schemes are also gaining traction to build confidence in local testing accuracy. Moreover, test kit companies are increasingly bundling their products with training modules and maintenance services for diagnostic capacity-building in underserved regions.

What Are the Primary Forces Propelling Growth in the Shigella Test Kits Market?

The growth in the global Shigella test kits market is driven by several factors that reflect the increasing prioritization of enteric disease diagnostics and rapid infectious disease surveillance. A primary growth driver is the rising incidence of shigellosis in both endemic and travel-associated populations, which has heightened the need for fast, reliable, and decentralized diagnostic solutions. With mounting antimicrobial resistance among Shigella strains, timely and precise identification of the causative agent is critical for effective treatment decisions and outbreak containment. Consequently, hospitals, clinics, and public health institutions are investing in diagnostic kits that align with AMR surveillance frameworks and WHO treatment guidelines.

Another major driver is the expansion of diagnostic infrastructure and funding across developing nations. Large-scale health surveys, donor-funded sanitation programs, and nutrition-focused child health campaigns are generating steady demand for Shigella test kits. The integration of diagnostic testing into routine immunization, prenatal screening, and school-based hygiene programs is expanding the use case for rapid and portable diagnostic tools. Multinational aid agencies and foundations are increasingly incorporating diagnostics into their WASH (Water, Sanitation, and Hygiene) program supply chains, recognizing the critical link between waterborne pathogens and undernutrition in children.

The growth trajectory is also supported by technological advancements in portable diagnostics, including isothermal amplification platforms, smartphone-enabled assays, and AI-driven result interpretation. These innovations are reducing the skill threshold and infrastructure requirements for accurate testing, thereby unlocking new end-user segments in mobile clinics, emergency response teams, and community health worker programs. As diagnostics become more integrated into broader public health interventions, the Shigella test kits market is expected to benefit from both vertical and horizontal demand across health systems.

SCOPE OF STUDY:

The report analyzes the Shigella Test Kits market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test, Other Test Types); Technology (Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology, Other Technologies); End-Use (Hospitals End-Use, Diagnostic Laboratories End-Use, Research Institutes End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Abbott Laboratories
• Alere Inc. (Abbott)
• BioMerieux SA
• BioPerfectus (BioPerfectus Tech)
• Bio-Rad Laboratories, Inc.
• Cepheid (Danaher)
• Coris BioConcept
• Creative Diagnostics
• CTK Biotech, Inc.
• DiaSorin S.p.A.
• Fujirebio Diagnostics, Inc.
• Hardy Diagnostics
• Hygiena LLC
• Luminex Corporation
• Meridian Bioscience, Inc.
• Molbio Diagnostics Pvt. Ltd.
• MP Biomedicals LLC
• QIAGEN N.V.
• Sekisui Diagnostics LLC
• Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Shigella Test Kits - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Incidence of Shigella Infections Throws the Spotlight on Rapid Diagnostic Solutions
  • Expansion of Food Safety Regulations Propels Adoption of Shigella Test Kits in Commercial Kitchens
  • Surge in Travel-Associated Gastrointestinal Disorders Drives Market Demand for Point-of-Care Testing
  • Advancements in Molecular Diagnostic Technologies Strengthen Business Case for PCR-Based Kits
  • Growth of Decentralized Diagnostics Accelerates Demand for At-Home and Field-Use Testing Solutions
  • Increased Focus on Early Detection in Pediatric and Geriatric Populations Spurs Diagnostic Expansion
  • Integration of AI-Powered Interpretation Tools Enhances Accuracy and Speed of Test Kits
  • Public Health Surveillance Programs Create Institutional Demand Across Urban and Rural Health Clinics
  • Growing Preference for Multiplex Pathogen Panels Boosts Bundled Testing Capabilities
  • Regulatory Approvals for Low-Cost Rapid Kits Strengthen Market Accessibility in Emerging Economies
  • Heightened Risk of Foodborne Illness in Mass Catering and Hospitality Drives Routine Screening Adoption
  • Strategic Stockpiling for Outbreak Preparedness Sustains Demand From Health Ministries and NGOs
  • Integration With Electronic Health Records Improves Case Tracking and Clinical Response
  • Educational Campaigns Around Waterborne Diseases Expand Awareness and Screening Compliance
  • Proliferation of Telemedicine and Remote Diagnostics Enhances Distribution of Home-Use Test Kits
  • Partnerships With Food Safety and Hygiene Monitoring Agencies Support Institutional Adoption
  • Development of Paper-Based and Disposable Test Formats Promotes Single-Use Applications
  • COVID-Era Investments in Diagnostic Infrastructure Spill Over Into Enteric Disease Detection
  • Increased Research Funding in Antimicrobial Resistance Encourages Test-Kit Innovation
  • Mobile Health Initiatives and Community Health Workers Expand Rural Reach of Shigella Testing
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Shigella Test Kits Market Analysis of Annual Sales in US$ for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Shigella Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Shigella Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Shigella Test Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Lateral Flow Assays Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Lateral Flow Assays Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Lateral Flow Assays Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Enzyme-linked Immunosorbent Assay Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Enzyme-linked Immunosorbent Assay Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction Assay Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Polymerase Chain Reaction Assay Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Polymerase Chain Reaction Assay Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Diagnostic Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Conventional Diagnostic Tests Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Conventional Diagnostic Tests Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Conventional Diagnostic Tests Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Nucleic Acid-based Tests Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Nucleic Acid-based Tests Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Nucleic Acid-based Tests Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 40: USA 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 43: USA 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 49: Canada 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• JAPAN
  • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 58: Japan 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 61: Japan 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 64: Japan 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• CHINA
  • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 65: China Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 67: China 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 70: China 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 73: China 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• EUROPE
  • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Shigella Test Kits by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Shigella Test Kits by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Shigella Test Kits by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• FRANCE
  • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 86: France Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 88: France 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 91: France 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 94: France 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• GERMANY
  • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 97: Germany 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 100: Germany 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 103: Germany 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 106: Italy 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 109: Italy 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 112: Italy 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 113: UK Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 115: UK 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 118: UK 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 121: UK 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 124: Spain 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 127: Spain 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 130: Spain 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 133: Russia 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 136: Russia 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 139: Russia 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Shigella Test Kits by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Shigella Test Kits by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for Shigella Test Kits by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 163: Australia 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 166: Australia 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 169: Australia 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• INDIA
  • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 170: India Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 172: India 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 175: India 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 178: India 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 181: South Korea 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 184: South Korea 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 187: South Korea 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Shigella Test Kits by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Shigella Test Kits by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for Shigella Test Kits by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 211: Argentina 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 214: Argentina 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 217: Argentina 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 220: Brazil 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 223: Brazil 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 226: Brazil 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 229: Mexico 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 232: Mexico 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 235: Mexico 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Shigella Test Kits by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Shigella Test Kits by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for Shigella Test Kits by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 259: Iran 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 262: Iran 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 265: Iran 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 268: Israel 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 271: Israel 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 274: Israel 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 286: UAE 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 289: UAE 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 292: UAE 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030
• AFRICA
  • Shigella Test Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Shigella Test Kits by Test Type - Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 304: Africa 16-Year Perspective for Shigella Test Kits by Test Type - Percentage Breakdown of Value Sales for Lateral Flow Assays Test, Enzyme-linked Immunosorbent Assay Test, Polymerase Chain Reaction Assay Test and Other Test Types for the Years 2014, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Shigella Test Kits by End-Use - Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 307: Africa 16-Year Perspective for Shigella Test Kits by End-Use - Percentage Breakdown of Value Sales for Research Institutes End-Use, Other End-Uses, Hospitals End-Use and Diagnostic Laboratories End-Use for the Years 2014, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Shigella Test Kits by Technology - Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 310: Africa 16-Year Perspective for Shigella Test Kits by Technology - Percentage Breakdown of Value Sales for Conventional Diagnostic Tests Technology, Nucleic Acid-based Tests Technology and Other Technologies for the Years 2014, 2025 & 2030

IV. COMPETITION